Engineered extracellular vesicles displaying bi-specific T-cell engagers for targeted therapy of B-cell malignancies
{{output}}
Despite the clinical success of T cell-based immunotherapies such as CAR-T cells and bispecific T cell engagers (BiTEs), therapeutic resistance and immune suppression remain significant barriers in B-cell malignancies. To address these, we developed a novel du... ...
